Skip to main content


Pediatric White Matter Injury

White matter injury (WMI), one of the most common consequences of premature birth, can produce long-term neurodevelopmental deficits. A study by researchers at Children’s National Hospital provides direct evidence that targeting specific receptors in white matter cells after brain injury promotes cellular and functional recovery.

In the United States, about 500,000 babies are born prematurely each year, with about 2% of them born at less than 32 weeks gestation. Up to 90% of these children survive, but they often suffer a number of abnormalities, including underdeveloped lungs. Underdeveloped lungs can lead to insufficient oxygen supply or hypoxia, which in turn contributes to WMI. No treatment currently exists to improve function in these infants once injury occurs.

During normal fetal and postnatal development, oligodendrocytes (myelin-producing cells in white matter) arise from oligodendrocyte progenitor cells (OPCs). In premature infants, hypoxia prevents OPCs from maturing properly, and the cells begin to die. Without sufficient myelin, the brain cannot process nerve impulses effectively, leading to significant delays in the development of sensorimotor skills and cognition.


Our team is standing by to schedule your child’s appointment.

    Departments that Treat White Matter Injury

    Neonatal Neurology and Neonatal Neurocritical Care Program

    The Neonatal Neurology and Neurocritical Care Program at Children's National is the only one of its kind in the mid-Atlantic region and a leader in advancing neurologic care to some of our most critically ill newborns.

    Pre-teen girl practicing balance for her provider


    Our pediatric neuroscience team is the largest in the country, allowing us to offer our vast experience to patients and families.